Comparative Pharmacology
Head-to-head clinical analysis: NANDROLONE DECANOATE versus XTRENBO.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NANDROLONE DECANOATE versus XTRENBO.
NANDROLONE DECANOATE vs XTRENBO
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nandrolone decanoate is an anabolic-androgenic steroid (AAS) that binds to androgen receptors (AR). Upon binding, it activates AR-mediated gene transcription, leading to increased protein synthesis, muscle growth, and bone density. It also exhibits some estrogenic activity via partial aromatization and progestogenic effects. It stimulates erythropoietin production in kidneys, increasing red blood cell mass.
XTRENBO (testosterone undecanoate) is an androgen receptor agonist. Testosterone binds to androgen receptors, activating gene transcription that leads to the development and maintenance of male secondary sexual characteristics. It also exerts anabolic effects.
50-200 mg intramuscularly every 2-4 weeks
0.25 mg intramuscularly once daily
None Documented
None Documented
Clinical Note
moderateAcarbose + Nandrolone decanoate
"Acarbose may increase the hypoglycemic activities of Nandrolone decanoate."
Clinical Note
moderateSunitinib + Nandrolone decanoate
"Sunitinib may increase the hypoglycemic activities of Nandrolone decanoate."
Clinical Note
moderatePrednisolone + Nandrolone decanoate
"Prednisolone may increase the fluid retaining activities of Nandrolone decanoate."
Clinical Note
moderateDexamethasone + Nandrolone decanoate
Terminal elimination half-life: approximately 6-7 days (range 4-14 days) after intramuscular injection; this long half-life supports every 2-4 week dosing intervals.
12-18 hours (terminal), requiring twice-daily dosing for sustained serum concentrations.
Renal: ~90% as metabolites (glucuronide and sulfate conjugates of 19-nortestosterone and its metabolites); fecal: ~6%; due to extensive hepatic metabolism, unchanged drug is not excreted in significant amounts.
Primarily renal (70%) as unchanged drug; 20% biliary/fecal; 10% metabolized to inactive glucuronides.
Category C
Category C
Anabolic Steroid
Anabolic Steroid
"Dexamethasone may increase the fluid retaining activities of Nandrolone decanoate."